Federman & Sherwood Investigates Cottrill's Specialty Pharmacy for Data Breach
OKLAHOMA CITY, March 19, 2025 (GLOBE NEWSWIRE) -- Federman & Sherwood investigates Cottrill's Specialty Pharmacy for data breach. On March 14, 2025, Cottrill's Specialty Pharmacy filed notice of a data breach with the Attorney General of Vermont. Cottrill's Specialty Pharmacy experienced a cybersecurity incident involving their network on or about January 21, 2025. Cottrill's Specialty Pharmacy immediately launched an investigation into the incident. The investigation determined that an unauthorized third party gained access to the Cottrill's Specialty Pharmacy network and accessed certain individuals’ personal and sensitive information. On March 14, 2025, Cottrill's Specialty Pharmacy began to send out data breach notification letters to all individuals impacted by the data breach.
The type of information potentially exposed includes:
- Full Name
- Date of Birth
- Social Security Number
- Driver’s License or State ID
- Medical Information
- Health Insurance Information
- Other sensitive information
Headquartered in Orchard Park, New York, Cottrill's Specialty Pharmacy is an independently owned pharmacy that specializes in the treatment of chronic conditions, genetic disorders, and rare diseases.
If received a data breach notice letter and you wish to discuss this action, obtain further information, and/or participate in this litigation, please contact Tashia Poore either by email at [email protected] or visit our firm’s website www.federmanlaw.com.
Tashia Poore
FEDERMAN & SHERWOOD
(405) 235-1560
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MAX Power Mining Corp. (OTC: MAXXF) (CSE: MAXX) Developing First Verified Subsurface Natural Hydrogen System in Canada
- Saudi: One Destination, Endless Ways to Explore
- Thailand Steps Into the Global Spotlight at TIFF 2026 as TAT Advances Its Film Location and Film Tourism Strategy
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share